Note the date of reconstitution, amount of water added, resulting concentration, and calculated draw volume for your target dose
The FDA placed it in 503A Category 2 ("may present significant safety risks") in 2023, effectively barring compounding pharmacies from using it, then removed it from that category in April 2026 after nominators withdrew their submission, without adding it to the approved Category 1 compounding list
Oral vitamin C is absorbed in the small intestine and transported to tissues until saturated
Seeing it laid out like this is illuminating, isn't it
Most of the research on BPC-157 has been conducted in animal studies , primarily in rats and mice
The tech who started last month